Tradestie Institutional Equity Comparison Engine

ABUS vs TEXN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABUS Overall Edge

ABUS Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Arbutus Biopharma Corporation Common Stock (ABUS) driven by superior Valuation, Growth & Margin, Options & Structure while TEXN counters with relative strength in Momentum & Technical. Fundamentally, ABUS trades at 10.2x Forward P/E with 80.1% operating margin (-43.5% YoY revenue) versus TEXN at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ABUS sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro) against TEXN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ABUS
ABUS 10.2x vs TEXN N/M Fwd P/E
Growth & Margin Winner ABUS
Op Margin 80.1% vs N/A ยท YoY -43.5% vs N/A
Momentum & Technical Winner TEXN
1Y -5.8% vs +9.2% ยท 52W Pos 27% vs 48%
Options & Structure Winner ABUS
CONSOLIDATION (18th %ile IV) vs UNCLASSIFIED (N/A IV)
ABUS NASDAQ
Arbutus Biopharma Corporation Common Stock
Pharmaceutical Preparations
$4.02
-1.23% 1D
Market Cap $623.9M
1M Return -4.51%
1Y Return -5.85%
Forward P/E 10.2x
Unified AI Score
43.4 / 100 HOLD
Tech 28.0 Fund 48.0 Flow 68.0 Mom 53.7
TEXN NASDAQ
iShares Texas Equity ETF
Institutional Equity
$30.09
-3.28% 1D
Market Cap N/A
1M Return -9.87%
1Y Return +9.16%
Forward P/E N/M
Unified AI Score
49.9 / 100 HOLD
Tech 43.0 Fund 53.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABUS -5.85% TEXN +9.16% Spread: +18.5 pp (TEXN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABUS TTM Op. Margin: 80.1% TEXN TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABUS vs TEXN. Trailing 12-month operating profitability (ABUS 80.1% vs TEXN N/A) and valuation multiples (ABUS 10.2x vs TEXN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABUS (7) vs TEXN (3)
Institutional Metric ABUS TEXN Criterion Row Winner
Market Capitalization Scale $623.9M N/A Larger Scale ABUS
Trailing P/E Ratio Valuation 3.6x N/M Lower Multiple ABUS
Forward P/E Ratio Valuation 10.2x N/M Lower Multiple ABUS
Revenue Growth (YoY) Growth -43.5% N/A Higher Growth ABUS
Operating Margin (TTM) Profitability 80.1% N/A Higher Margin ABUS
Net Profit Margin Profitability 121.2% N/A Higher Margin ABUS
Return on Equity (ROE) Capital Efficiency 269.6% N/A Higher ROE ABUS
52-Week Range Position Momentum 27% ($4โ€“$5) 48% ($26โ€“$34) Stronger Trend TEXN
Beta / 30D Volatility Risk Regime 1.04ฮฒ ยท 48% Vol 0.71ฮฒ ยท 28% Vol Lower Realized Risk TEXN
Unified Institutional Score Composite Signal 43.4 / 100 (HOLD) 49.9 / 100 (HOLD) Higher Composite TEXN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABUS vs TEXN Buy Guide
ABUS CONSOLIDATION
96d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live ABUS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TEXN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live TEXN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABUS nor TEXN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.